APA

Wong J. Y. C., Chu D. Z., Williams L. E., Liu A., Zhan J., Yamauchi D. M., Wilczynski S., Wu A. M., Yazaki P. J., Shively J. E., Leong L. & Raubitschek A. A. (20060718). A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. : Cancer biotherapy & radiopharmaceuticals.

Chicago

Wong Jeffrey Y C, Chu David Z, Williams Lawrence E, Liu An, Zhan Jiping, Yamauchi Dave M, Wilczynski Sharon, Wu Anna M, Yazaki Paul J, Shively John E, Leong Lucille and Raubitschek Andrew A. 20060718. A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. : Cancer biotherapy & radiopharmaceuticals.

Harvard

Wong J. Y. C., Chu D. Z., Williams L. E., Liu A., Zhan J., Yamauchi D. M., Wilczynski S., Wu A. M., Yazaki P. J., Shively J. E., Leong L. and Raubitschek A. A. (20060718). A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. : Cancer biotherapy & radiopharmaceuticals.

MLA

Wong Jeffrey Y C, Chu David Z, Williams Lawrence E, Liu An, Zhan Jiping, Yamauchi Dave M, Wilczynski Sharon, Wu Anna M, Yazaki Paul J, Shively John E, Leong Lucille and Raubitschek Andrew A. A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. : Cancer biotherapy & radiopharmaceuticals. 20060718.